Phase I/II Trial of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy and Surgery for Locoregionally Advanced Pancreatic Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/content/pdf/10.1245/s10434-008-0152-3.pdf
Reference58 articles.
1. Jemal A, Thomas A, Murray T, et al. Cancer Statistics. CA Cancer J Clin 2002;52:23–47.
2. Heinemann V, Quietzsch D, Gieseler F, et al. Randomized Phase III trial of gemcitabine pulse cisplatin compared with gemcitabine alone in advanced pancreatic cancer. J Clin Oncol 2006;24:3946–52.
3. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of disease, in the west midlands: an epidemiological study. Br J Sur 1985;82:111–5.
4. Parker S, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 1997;47:5–27.
5. Trede M, Schwal G, Saeger H, et al. Survival after pancreaticoduodenectomy. Ann Surg 1990;211:447–58.
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderline Resectable Pancreatic Adenocarcinoma;The American Surgeon™;2024-04-18
2. Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas Cancer;American Journal of Clinical Oncology;2022-10-21
3. Management of Resectable and Borderline Resectable Disease: Medical Oncology;Pancreatic Cancer: A Multidisciplinary Approach;2022
4. Nonsurgical Management of Pancreatic Adenocarcinoma;Hepato-Pancreato-Biliary Malignancies;2022
5. Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis;Clinical and Translational Radiation Oncology;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3